Patent ID: 8383613
Filing Date: 2013-02-26
Classification: A61K,A61P,C07D

Abstract:
1. A method for treating a cancer in a patient in need thereof comprising administering to said patient, concurrently or sequentially, a therapeutically effective amount of at least one indoleamine 2,3-dioxygenase (IDO) inhibitor and at least one chemotherapeutic agent, wherein said IDO inhibitor is 1-methyl-trypophan, wherein said at least one chemotherapeutic agent is selected from the group consisting of paclitaxel, cisplatin, cyclophosphamide, gemcitabine, and doxorubicin, and wherein said cancer is selected from the group consisting of ovarian cancer, leukemia, melanoma, breast cancer, colorectal cancer, and lung cancer.